SPECIFY

Completed study

Official Study Title
Scoring PErsonalized needs in Clostridium difficile Infections for Fidaxomixin therapY

Brief Description
The SPECIFY study is a non-interventional study aiming to develop a complex score composed by clinical data, genomic data and protein biomarkers to early predict patients with infection by Clostridium difficile at high likelihood to develop organ failure, relapse of the infection or die.

Details
Status: Completed
Study Type: Non-Interventional
Study phase: II
Study sites: 12 sites in Greece
Actual enrolment: 153 participants

ClinicalTrials.gov Identifier: NCT02573571

Study Start: October 2015
Study Completion: October 2017

Condition/Disease studied: Biologic Markers; Clinical Markers
Keywords: single nucleotide polymorphisms; cytokines; microbiome